OPRX News and Press, OptimizeRx Corporation From 03/25/19

I have been studying what effect uplisting has on the stock price of individual stocks. My first article concluded that a profit exceeding 25% was available in 65% of stocks that had uplisted during 2015 but that profit evaporated within the first year after uplisting. Only 10% of these same...

ROCHESTER, Mich., March 20, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading digital health messaging platform for the pharmaceutical industry , released its full results and findings from its Drug Cost Survey. The survey focused on prescription drug costs, yielding i...

ROCHESTER, Mich., March 04, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading digital health messaging platform for the pharmaceutical industry, has been invited to present at the 31st Annual ROTH Conference being held at The Ritz Carlton, Laguna Niguel in Orange Count...

OptimizeRx Corp. (OPRX) Q4 2018 Earnings Conference Call February 26, 2019 4:30 PM ET Company Participants William Febbo – Chief Executive Officer Doug Baker – Chief Financial Officer Miriam Paramore – President Conference Call Participants Andrew D...

Healthcare communications specialist OptimizeRx (NASDAQ: OPRX ) is up 19.8% after hours following a solid beat on revenues in Q4 along with guidance for healthy growth in 2019. More news on: OptimizeRx Corp., Stocks on the move, Earnings news and commentary, , Read more ...

OptimizeRx (NASDAQ: OPRX ): Q4 Non-GAAP EPS of $0.06 in-line; GAAP EPS of -$0.01 in-line. More news on: OptimizeRx Corp., Earnings news and commentary, Consumer stocks news, , Read more ...

ROCHESTER, Mich., Feb. 26, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, reported results for the fourth quarter and year ended December 31, 2018. Quarterly comparisons are to the same year-ago q...

ROCHESTER, Mich., Feb. 13, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, will hold a conference call on Tuesday, February 26, 2019 at 4:30 p.m. Eastern time to discuss results for the fourth quar...

ROCHESTER, Mich., Feb. 11, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, announced today its initial findings from a physician survey focused on prescription drug costs. The Drug Cost Survey yiel...

ROCHESTER, Mich., Feb. 07, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, has formed OptimizeMDs, a multi-specialty physician panel with the mission of improving the effectiveness of digital healt...